Sanara MedTech (SMTI) EBIAT (2016 - 2025)
Historic EBIAT for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to -$30.4 million.
- Sanara MedTech's EBIAT fell 95485.81% to -$30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.7 million, marking a year-over-year decrease of 34441.4%. This contributed to the annual value of -$9.9 million for FY2024, which is 12324.59% down from last year.
- Latest data reveals that Sanara MedTech reported EBIAT of -$30.4 million as of Q3 2025, which was down 95485.81% from -$2.0 million recorded in Q2 2025.
- In the past 5 years, Sanara MedTech's EBIAT ranged from a high of $769426.0 in Q2 2022 and a low of -$30.4 million during Q3 2025
- For the 5-year period, Sanara MedTech's EBIAT averaged around -$3.5 million, with its median value being -$1.9 million (2023).
- As far as peak fluctuations go, Sanara MedTech's EBIAT tumbled by 123478.89% in 2021, and later skyrocketed by 16380.13% in 2022.
- Sanara MedTech's EBIAT (Quarter) stood at -$3.6 million in 2021, then fell by 17.06% to -$4.2 million in 2022, then soared by 93.7% to -$262444.0 in 2023, then crashed by 547.99% to -$1.7 million in 2024, then crashed by 1688.32% to -$30.4 million in 2025.
- Its EBIAT stands at -$30.4 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$3.5 million for Q1 2025.